Successful twin pregnancy outcome after in utero exposure to FOLFOX for metastatic colon cancer: a case report and review of the literature

Keyphrases

• Pregnancy Outcome 100%
• Metastatic Colorectal Cancer (mCRC) 100%
• In Utero Exposure 100%
• Twin Pregnancy 100%
• FOLFIRINOX 100%
• Third Trimester 66%
• Gestational Age 66%
• Cancer Diagnosis 33%
• Older Women 33%
• During Pregnancy 33%
• First Trimester 33%
• Colorectal Cancer 33%
• Follow-up Examination 33%
• Second Trimester 33%
• Treatment Delay 33%
• Chemotherapy 33%
• Malformation 33%
• Fetus 33%
• Second Trimester of Pregnancy 33%
• Oxaliplatin 33%
• Giving Birth 33%
• Advanced Colorectal Cancer 33%
• Systemic Chemotherapy 33%
• Rare Occurrence 33%
• Maternal Survival 33%
• Healthy Twins 33%
• 2-year-olds 33%
• Fetal Harm 33%
• 5-fluorouracil/leucovorin 33%

Medicine and Dentistry

• Twin Pregnancy 100%
• FOLFOX 100%
• Metastatic Colon Cancer 100%
• Malignant Neoplasm 66%
• Third Trimester Pregnancy 66%
• Second Trimester Pregnancy 66%
• Colorectal Carcinoma 66%
• Gestational Age 66%
• Chemotherapy 66%
• First Trimester Pregnancy 33%
• Congenital Malformation 33%
• Cancer Diagnosis 33%
• Fluorouracil 33%
• Folinic Acid 33%
• Oxaliplatin 33%
• Pregnant Woman 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Metastatic Colon Cancer 100%
• Twin Pregnancy 100%
• Chemotherapy Regimens 66%
• Colorectal Carcinoma 66%
• Fluorouracil 33%
• Congenital Malformation 33%
• Oxaliplatin 33%
• Folinic Acid 33%